-
- Goto Hidemasa
- Division of Biochemistry, Aichi Cancer Center Research Institute Department of Cellular Oncology, Nagoya University Graduate School of Medicine
-
- Kasahara Kousuke
- Division of Biochemistry, Aichi Cancer Center Research Institute Department of Oncology, Graduate School of Pharmaceutical Sciences, Nagoya City University
-
- Inagaki Masaki
- Division of Biochemistry, Aichi Cancer Center Research Institute Department of Cellular Oncology, Nagoya University Graduate School of Medicine
この論文をさがす
抄録
Checkpoint kinase 1 (Chk1) is a conserved protein kinase central to the cell-cycle checkpoint during DNA damage response (DDR). Until recently, ATR, a protein kinase activated in response to DNA damage or stalled replication, has been considered as the sole regulator of Chk1. Recent progress, however, has led to the identification of additional protein kinases involved in Chk1 phosphorylation, affecting the subcellular localization and binding partners of Chk1. In fact, spatio-temporal regulation of Chk1 is of critical importance not only in the DDR but also in normal cell-cycle progression. In due course, many potent inhibitors targeted to Chk1 have been developed as anticancer agents and some of these inhibitors are currently in clinical trials. In this review, we summarize the current knowledge of Chk1 regulation by phosphorylation.
収録刊行物
-
- Cell Structure and Function
-
Cell Structure and Function 40 (1), 43-50, 2015
日本細胞生物学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282679673264896
-
- NII論文ID
- 130004885867
-
- NII書誌ID
- AA0060007X
-
- ISSN
- 13473700
- 03867196
-
- NDL書誌ID
- 027281665
-
- PubMed
- 25748360
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可